That was my exact point Minimoke, long term is the ideal scenario.
A2 has more than enough capacity to handle all the needs for Chinese and US markets ( and the rest of us esp Aust, NZ, South Korea)
- Forums
- ASX - By Stock
- A2M
- FDA Approval
FDA Approval, page-3
-
- There are more pages in this discussion • 316 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.77 |
Change
0.190(2.89%) |
Mkt cap ! $4.894B |
Open | High | Low | Value | Volume |
$6.64 | $6.80 | $6.62 | $8.993M | 1.334M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5191 | $6.76 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.82 | 2584 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 6.720 |
1 | 8000 | 6.700 |
1 | 5000 | 6.620 |
2 | 1100 | 6.600 |
1 | 760 | 6.520 |
Price($) | Vol. | No. |
---|---|---|
6.830 | 750 | 1 |
6.850 | 535 | 1 |
6.860 | 10000 | 1 |
6.900 | 11758 | 4 |
6.930 | 1420 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |